Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 4—April 2008


Emericella quadrilineata as Cause of Invasive Aspergillosis

Paul E. Verweij*Comments to Author , János Varga†‡, Jos Houbraken†, Antonius J.M.M. Rijs*, Frans M. VerduynLunel*, Nicole M.A. Blijlevens*, Yvonne R. Shea§, Steven M. Holland§, Adilia Warris*, Willem J. G. Melchers*, and Robert A. Samson†
Author affiliations: *Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; †Centraal Bureau voor Schimmelcultures Fungal Biodiversity Centre, Utrecht, the Netherlands,; ‡University of Szeged, Szeged, Hungary; §National Institutes of Health, Bethesda, Maryland, USA;

Main Article


Antifungal activities against Emericella nidulans and E. quadrilineata

Drug MIC, mean
E. nidulans (n = 12) E. quadrilineata (n = 12)
Amphotericin B 2.5 0.5 p<0.05
Itraconazole 0.07 0.13 NS
Voriconazole 0.26 0.39 p<0.05
Posaconazole 0.25 0.22 p<0.05
Caspofungin† 0.32 1.83 p<0.05
Terbinafine 0.01 0.009 NS

*NS, not significant.
†Mean minimum effective concentration was compared.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO